HTG Demonstrates Technical Feasibility for a Whole Transcriptome Panel Using HTGÂ EdgeSeq Technology
TUCSON, Ariz. , Nov. 02, 2020 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced the completion of proof of concept for a whole transcriptome panel using the HTG EdgeSeq technology, and
- Category:
- Press Releases